XWELL stock analysis
XWELL (V9G0) Stock Price & Analysis
V9G0 Stock Chart & Stats
- Day’s Range
- EUR 1.42 - EUR 1.43
- 52-Week Range
- EUR 1.42 - EUR 1.43
- Previous Close
- EUR 1.43
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 5.09M
- Enterprise Value
- EUR 14.45M
- Total Cash (Recent Filing)
- EUR 11.78M
- Total Debt (Recent Filing)
- EUR 7.29M
- Price to Earnings (P/E)
- ―
- Beta
- N/A
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strategic Sale Approval
Shareholder approval gives XWELL a formally supported path to execute its proposed strategic sale and simplify its portfolio. Completion could sharpen management focus and alter the company’s operating structure, although the durable benefit depends on successful closing and implementation.
Debt Reduction And Asset Growth
Debt reduction and asset growth provide some improvement in financial positioning despite the company’s broader balance-sheet stress. Lower borrowings may reduce financing pressure and create more flexibility for the strategic transition, though negative equity still limits the strength of this advantage.
Improved Gross Profitability
Improvement in gross profitability indicates that the underlying service economics have recovered from their 2023 low point. If maintained, better gross margins could support operating improvement and help the company convert revenue into cash more effectively, even though current costs remain too high.
Bears Say
Losses, Revenue Decline And Negative Equity
Deep operating losses, sharply lower revenue and negative equity indicate that XWELL has not yet established a durable earnings base. This combination weakens resilience, limits financial flexibility and makes any strategic transition more dependent on reversing declining sales and controlling costs.
Persistent Cash Consumption
Persistent operating and free-cash-flow deficits show that the business continues to consume cash rather than fund itself. Ongoing cash use can increase dependence on financing, asset sales or equity issuance, while the absence of breakeven reduces flexibility to invest in growth or absorb setbacks.
Nasdaq Listing Compliance Risk
The Nasdaq notice creates a continuing operational and capital-markets risk over the next several months. Failure to restore the required bid price could lead to delisting proceedings, while a potential reverse split may add execution complexity and further constrain investor access.
XWELL News
V9G0 FAQ
What was XWELL’s price range in the past 12 months?
What is XWELL’s market cap?
When is XWELL’s upcoming earnings report date?
How were XWELL’s earnings last quarter?
Is XWELL overvalued?
Does XWELL pay dividends?
What is XWELL’s EPS estimate?
How many shares outstanding does XWELL have?
What happened to XWELL’s price movement after its last earnings report?
Which hedge fund is a major shareholder of XWELL?
What is the TipRanks Smart Score and how is it calculated?
Company Description
XWELL
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
- Sector
- Healthcare
- Industry
- Personal Products & Services
- CEO
- Ezra T. Ernst
- Employees
- 175
- Website
- www.xwell.com
- Address
- 254 West 31st Street, New York City, NY, 10001, US
XWELL (V9G0) Earnings & Revenues
V9G0 Earnings Call
Earnings Call SentimentPositive
The earnings call highlighted significant progress in revenue growth, strategic market expansion, and cost reductions, with improved financial metrics compared to the previous year. However, there were challenges such as increased salaries and legal expenses. Overall, the positive aspects and strategic advancements outweigh the negatives.
View all DE:V9G0 earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 5 | 10 |
| Technical Analysis | 1 | 0 | 3 |
| Moving Averages | 0 | 5 | 7 |













